Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trends in pediatric uveitis: A systematic review and meta-epidemiological investigation of geographic, economic, and climate factors.

Survey of ophthalmology·2026
Same author

Birdshot Chorioretinopathy with Double-Layer Sign and Choroidal Neovascularization: A Single-Centre Analysis.

Ocular immunology and inflammation·2025
Same author

Enrollment of race/ethnicity in ophthalmic clinical trials before and after the Final Rule.

Journal of the National Medical Association·2025
Same author

Epidemiology of Pediatric Uveitis in Argentina.

Journal of pediatric ophthalmology and strabismus·2023
Same author

Diverse Research Teams and Underrepresented Groups in Clinical Studies.

JAMA ophthalmology·2023
Same author

Follow-Up Adherence After Community Health Vision Screening Programs: A Review of the Literature.

Journal of academic ophthalmology (2017)·2023

Related Experiment Video

Updated: Feb 8, 2026

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

3.2K

What is new in paediatric uveitis?

Kara C LaMattina1, Anjum F Koreishi2

  • 1Boston University School of Medicine, Boston, Massachusetts.

Current Opinion in Ophthalmology
|July 3, 2018
PubMed
Summary

Paediatric uveitis, often chronic and noninfectious, varies geographically. New biologic agents offer improved treatment options for these sight-threatening childhood eye conditions.

More Related Videos

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

6.1K
Human Colonoid Monolayers to Study Interactions Between Pathogens, Commensals, and Host Intestinal Epithelium
07:20

Human Colonoid Monolayers to Study Interactions Between Pathogens, Commensals, and Host Intestinal Epithelium

Published on: April 9, 2019

9.8K

Related Experiment Videos

Last Updated: Feb 8, 2026

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

3.2K
Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

6.1K
Human Colonoid Monolayers to Study Interactions Between Pathogens, Commensals, and Host Intestinal Epithelium
07:20

Human Colonoid Monolayers to Study Interactions Between Pathogens, Commensals, and Host Intestinal Epithelium

Published on: April 9, 2019

9.8K

Area of Science:

  • Ophthalmology
  • Pediatrics
  • Immunology

Background:

  • Paediatric uveitis is a significant cause of vision loss in children.
  • Understanding its epidemiology and etiology is crucial for effective management.

Purpose of the Study:

  • To summarize the demographics and causes of paediatric uveitis.
  • To review current treatment strategies for noninfectious paediatric uveitis.

Main Methods:

  • Systematic review of recent epidemiological and therapeutic literature.
  • Analysis of geographical variations in paediatric uveitis causes.
  • Evaluation of emerging biologic therapies.

Main Results:

  • Geographical variations in paediatric uveitis causes reported globally.
  • Noninfectious causes are predominant in most paediatric uveitis cases worldwide.
  • Biologic agents represent a significant advancement in treating noninfectious paediatric uveitis.

Conclusions:

  • Most paediatric uveitis cases are chronic and noninfectious.
  • Treatment options for noninfectious paediatric uveitis have expanded significantly.
  • Advances in therapeutics offer hope for better visual outcomes in affected children.